Volker Tronnier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Volker Tronnier has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Dirk Rasche
Department of Neurosurgery, University of Lübeck, Lübeck, Germany
3 shared publications D. Rasche
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
2 shared publicationsDieter Horstkotte
Ruhr-Universität Bochum
2 shared publicationsFrank Birklein
Universitätsmedizin Mainz
2 shared publicationsRalf Baron
Universitätsklinikum Schleswig-Holstein, Campus Kiel
2 shared publicationsSiegfried Eckert
Ruhr-Universität Bochum
2 shared publications
Latest Publications
- 28 September 2016
- Vol. 19 (7) , 507-18
Subtle Sensory Abnormalities Detected by Quantitative Sensory Testing in Patients with Trigeminal Neuralgia.
Trigeminal neuralgia (TN) is characterized by paroxysmal pain attacks affecting the somatosensory distributions of the trigeminal nerve. It is thought to be associated with a neurovascular conflict most frequently, but pathomechanisms have not been fully elucidated. In general, no sensory deficit is found in routine clinical examination. There is limited data available, however, showing subtle subclinical sensory deficits upon extensive testing. We used quantitative sensory testing (QST) to detect abnormalities in sensory processing in patients with TN by comparing the affected and non-affected nerve branches with their contralateral counterparts and by comparing the results of the patients with those of controls. Observational study. University Hospital, Departments of Neurosurgery, Institute for Cognitive and Clinical Neuroscience. QST was conducted on 48 patients with idiopathic TN and 27 controls matched for age and gender using the standardized protocol of the German Neuropathic Pain Network. Stimulations were performed bilaterally in the distribution of the trigeminal branches. The patients had no prior invasive treatment, and medications at the time of examination were noted. In patients with TN deficits in warm and cold sensory detection thresholds in the affected and also the non-affected nerve branches were found. Tactile sensation thresholds were elevated in the involved nerve branches compared to the contralateral side. More data are needed on the correlation of such findings with the length of history of TN and with changes of the morphology of the trigeminal nerve. QST shows subtle sensory abnormalities in patients with TN despite not being detected in routine clinical examination. Our data may provide a basis for further research on the development of TN and also on improvement after treatment. Quantitative sensory testing, trigeminal neuralgia, facial pain, neuropathic pain, microvascular decompression, cranial nerve.
- 28 September 2016
- Vol. 19 (7) , 507-18
Subtle Sensory Abnormalities Detected by Quantitative Sensory Testing in Patients with Trigeminal Neuralgia.
Trigeminal neuralgia (TN) is characterized by paroxysmal pain attacks affecting the somatosensory distributions of the trigeminal nerve. It is thought to be associated with a neurovascular conflict most frequently, but pathomechanisms have not been fully elucidated. In general, no sensory deficit is found in routine clinical examination. There is limited data available, however, showing subtle subclinical sensory deficits upon extensive testing. We used quantitative sensory testing (QST) to detect abnormalities in sensory processing in patients with TN by comparing the affected and non-affected nerve branches with their contralateral counterparts and by comparing the results of the patients with those of controls. Observational study. University Hospital, Departments of Neurosurgery, Institute for Cognitive and Clinical Neuroscience. QST was conducted on 48 patients with idiopathic TN and 27 controls matched for age and gender using the standardized protocol of the German Neuropathic Pain Network. Stimulations were performed bilaterally in the distribution of the trigeminal branches. The patients had no prior invasive treatment, and medications at the time of examination were noted. In patients with TN deficits in warm and cold sensory detection thresholds in the affected and also the non-affected nerve branches were found. Tactile sensation thresholds were elevated in the involved nerve branches compared to the contralateral side. More data are needed on the correlation of such findings with the length of history of TN and with changes of the morphology of the trigeminal nerve. QST shows subtle sensory abnormalities in patients with TN despite not being detected in routine clinical examination. Our data may provide a basis for further research on the development of TN and also on improvement after treatment. Quantitative sensory testing, trigeminal neuralgia, facial pain, neuropathic pain, microvascular decompression, cranial nerve.
- 19 August 2015
- Published by Springer Nature
- p. 377-384
Intrathekale Therapie, Pumpen, Pumpenversagen
- 1 March 2015
- Published by Georg Thieme Verlag KG in Journal Club Schmerzmedizin
- Vol. 4 (01) , 50-52
Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen – Das Wichtigste aus der aktualisierten Leitlinie
Im Februar 2014 wurde die 2. Auflage der der S3-Leitlinie „Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen“ veröffentlicht (AWMF-Registernr. 008-23). Vorausgegangen war eine erste Version im Jahre 2010, zu der auch eine Publikation in „Der Schmerz“ vorliegt [1]. Diese S3-Leitlinie löste eine Expertenempfehlung aus dem Jahr 2003 [2] ab und legte erstmals eine fachübergreifende Empfehlung für ein invasives schmerztherapeutisches Verfahren vor.
- 1 March 2015
- Published by Georg Thieme Verlag KG in Journal Club Schmerzmedizin
- Vol. 4 (01) , 50-52
Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen – Das Wichtigste aus der aktualisierten Leitlinie
Im Februar 2014 wurde die 2. Auflage der der S3-Leitlinie „Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen“ veröffentlicht (AWMF-Registernr. 008-23). Vorausgegangen war eine erste Version im Jahre 2010, zu der auch eine Publikation in „Der Schmerz“ vorliegt [1]. Diese S3-Leitlinie löste eine Expertenempfehlung aus dem Jahr 2003 [2] ab und legte erstmals eine fachübergreifende Empfehlung für ein invasives schmerztherapeutisches Verfahren vor.
- 3 December 2014
- Published by Springer Nature
- p. 1-35
Interventionelle Verfahren in der Schmerztherapie
- 23 August 2013
- Published by Georg Thieme Verlag KG in Im OP
- Vol. 3 (05) , 202-207
Die Tiefe Hirnstimulation
OP-Ablauf Fehlfunktionen und Krankheiten im menschlichen Gehirn sind oft mit weitreichenden Folgen verbunden. Die operative Therapie in diesem Gebiet ist schwierig und riskant. Am Universitätsklinikum Schleswig-Holstein werden Parkinson-Patienten, chronischen Schmerzpatienten und Patienten mit Bewegungsstörung mit der Tiefen Hirnstimulation therapiert. Denn in manchen Fällen kann eine kleine Elektrode im Gehirn die Lebensqualität deutlich verbessern.
- 23 August 2013
- Published by Georg Thieme Verlag KG in Im OP
- Vol. 3 (05) , 202-207
Die Tiefe Hirnstimulation
OP-Ablauf Fehlfunktionen und Krankheiten im menschlichen Gehirn sind oft mit weitreichenden Folgen verbunden. Die operative Therapie in diesem Gebiet ist schwierig und riskant. Am Universitätsklinikum Schleswig-Holstein werden Parkinson-Patienten, chronischen Schmerzpatienten und Patienten mit Bewegungsstörung mit der Tiefen Hirnstimulation therapiert. Denn in manchen Fällen kann eine kleine Elektrode im Gehirn die Lebensqualität deutlich verbessern.
- Open Access
- 3 July 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 162
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases
This retrospective study investigated the outcome of patients with brain metastases after radiosurgery with special emphasis on prognostic impact of visible intratumoral necrosis on survival and local control. From 1998 through 2008, 149 patients with brain metastases from solid tumors were treated with stereotactic radiotherapy at Luebeck University. Median age was 58.4 years with 11%, 78%, 10% in recursive partitioning analysis (RPA) classes I, II, III, respectively. 70% had 1 metastasis, 29% 2-3 metastases, 2 patients more than 3 metastases, 71% active extracranial disease. Median volume of metastatic lesions was 4.7 cm3, median radiosurgery dose 22 Gy (single fraction). 71% of patients received additional whole-brain irradiation (WBI). All patients were analyzed regarding survival, local, distant failure and prognostic factors, side effects and changes in neurologic symptoms after radiotherapy. The type of contrast-enhancement in MR imaging was also analyzed; metastatic lesions were classified as containing necrosis if they appeared as ring-enhancing with central areas of no or minimal contrast enhancement. Median survival was 7.0 months with 1-year and 5-year survival rates of 33% and 0.4%, respectively. Tumor necrosis (ring-enhancement) was visible on pretreatment MRI scans in 56% of all lesions and lesions with necrosis were larger than non-necrotic lesions (6.7 cm3 vs. 3.2 cm3, p = 0.01). Patients with tumor necrosis had a median survival of 5.4 months, patients without tumor necrosis 7.2 months. Local control rate in the irradiated volume was 70%, median survival without local failure 17.8 months. Control in the brain outside the irradiated volume was 60%, median survival without distant failure 14.0 months. Significant prognostic factors for overall survival were KPS (p = 0.001), presence of tumor necrosis on pretreatment MRI (p = 0.001) with RPA-class and WBI reaching marginal significance (each p = 0.05). Prognostic impact of tumor necrosis remained significant if only smaller tumors with a volume below 3.5 cm3 (p = 0.03). Side effects were rare, only one patient suffered from serious acute side effects. Results of this retrospective study support that stereotactic radiotherapy is an effective treatment option for patients with metastatic brain lesions. The prognostic impact of visible tumor necrosis (ring-enhancement) on pretreatment MRI scans should be further investigated.
- 3 July 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 162
Open AccessThe prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases
This retrospective study investigated the outcome of patients with brain metastases after radiosurgery with special emphasis on prognostic impact of visible intratumoral necrosis on survival and local control. From 1998 through 2008, 149 patients with brain metastases from solid tumors were treated with stereotactic radiotherapy at Luebeck University. Median age was 58.4 years with 11%, 78%, 10% in recursive partitioning analysis (RPA) classes I, II, III, respectively. 70% had 1 metastasis, 29% 2-3 metastases, 2 patients more than 3 metastases, 71% active extracranial disease. Median volume of metastatic lesions was 4.7 cm3, median radiosurgery dose 22 Gy (single fraction). 71% of patients received additional whole-brain irradiation (WBI). All patients were analyzed regarding survival, local, distant failure and prognostic factors, side effects and changes in neurologic symptoms after radiotherapy. The type of contrast-enhancement in MR imaging was also analyzed; metastatic lesions were classified as containing necrosis if they appeared as ring-enhancing with central areas of no or minimal contrast enhancement. Median survival was 7.0 months with 1-year and 5-year survival rates of 33% and 0.4%, respectively. Tumor necrosis (ring-enhancement) was visible on pretreatment MRI scans in 56% of all lesions and lesions with necrosis were larger than non-necrotic lesions (6.7 cm3 vs. 3.2 cm3, p = 0.01). Patients with tumor necrosis had a median survival of 5.4 months, patients without tumor necrosis 7.2 months. Local control rate in the irradiated volume was 70%, median survival without local failure 17.8 months. Control in the brain outside the irradiated volume was 60%, median survival without distant failure 14.0 months. Significant prognostic factors for overall survival were KPS (p = 0.001), presence of tumor necrosis on pretreatment MRI (p = 0.001) with RPA-class and WBI reaching marginal significance (each p = 0.05). Prognostic impact of tumor necrosis remained significant if only smaller tumors with a volume below 3.5 cm3 (p = 0.03). Side effects were rare, only one patient suffered from serious acute side effects. Results of this retrospective study support that stereotactic radiotherapy is an effective treatment option for patients with metastatic brain lesions. The prognostic impact of visible tumor necrosis (ring-enhancement) on pretreatment MRI scans should be further investigated.
- 26 February 2012
- Published by Springer Nature in Der Schmerz
- Vol. 26 (1) , 45
Erratum zu: Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen. Zusammenfassung der S3-Leitlinie
- 26 February 2012
- Published by Springer Nature in Der Schmerz
- Vol. 26 (1) , 45
Erratum zu: Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen. Zusammenfassung der S3-Leitlinie
- 23 September 2011
- Published by Springer Nature in Der Schmerz
- Vol. 25 (5) , 484-492
Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen
Epidural spinal cord stimulation (SCS) is a reversible but invasive procedure which should be used for neuropathic pain, e.g. complex regional pain syndrome I (CRPS) and for mostly chronic radiculopathy in connection with failed back surgery syndrome following unsuccessful conservative therapy. Epidural SCS can also successfully be used after exclusion of curative procedures and conservative therapy attempts for vascular-linked pain, such as in peripheral arterial occlusive disease stages II and III according to Fontaine and refractory angina pectoris. Clinical practice has shown which clinical symptoms cannot be successfully treated by epidural SCS, e.g. pain in complete paraplegia syndrome or atrophy/injury of the sensory pathways of the spinal cord or cancer pain. A decisive factor is a critical patient selection as well as the diagnosis. Epidural SCS should always be used within an interdisciplinary multimodal therapy concept. Implementation should only be carried out in experienced therapy centers which are in a position to deal with potential complications.
- 23 September 2011
- Published by Springer Nature in Der Schmerz
- Vol. 25 (5) , 484-492
Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen
Epidural spinal cord stimulation (SCS) is a reversible but invasive procedure which should be used for neuropathic pain, e.g. complex regional pain syndrome I (CRPS) and for mostly chronic radiculopathy in connection with failed back surgery syndrome following unsuccessful conservative therapy. Epidural SCS can also successfully be used after exclusion of curative procedures and conservative therapy attempts for vascular-linked pain, such as in peripheral arterial occlusive disease stages II and III according to Fontaine and refractory angina pectoris. Clinical practice has shown which clinical symptoms cannot be successfully treated by epidural SCS, e.g. pain in complete paraplegia syndrome or atrophy/injury of the sensory pathways of the spinal cord or cancer pain. A decisive factor is a critical patient selection as well as the diagnosis. Epidural SCS should always be used within an interdisciplinary multimodal therapy concept. Implementation should only be carried out in experienced therapy centers which are in a position to deal with potential complications.
- 26 September 2010
- Published by Springer Nature in Der Schmerz
- Vol. 24 (5) , 441-448
Subkutane periphere Stimulation des N. occipitalis major zur Behandlung chronischer Kopfschmerzsyndrome
Die medikamentöse Therapie bestimmter Kopfschmerzsyndrome wie der chronischen Hemikranie (HC), chronischen Migräne (CM) oder dem chronischen Cluster-Kopfschmerz (CCH) führt in vielen Fällen nicht zu befriedigenden Ergebnissen oder ist durch intolerable Nebenwirkungen erschwert. In den letzten Jahren haben sich auch für diese Schmerzerkrankungen neuromodulative Therapien wie die subkutane Stimulation des N. occipitalis major oder die tiefe Hirnstimulation (DBS) im Hypothalamus entwickelt. Diese Arbeit soll eine Übersicht über den derzeitigen Wissensstand und die Resultate der subkutanen peripheren Nervenstimulation (SPNS) in der Literatur bei den beschriebenen Kopfschmerzformen geben und eigene Ergebnisse bei insgesamt 10 Patienten vorstellen. Hierbei wird auf technische Details bei der Implantation und mögliche Komplikationen eingegangen. Die Ergebnisse bei Cluster-Kopfschmerz werden mit denen der tiefen Hirnstimulation verglichen. Zusammenfassend lässt sich sagen, dass die SPNS beim Cluster-Kopfschmerz als weniger invasives Verfahren zwar nicht so erfolgreich ist wie die tiefe Hirnstimulation, aber dennoch die Häufigkeit und Schwere der Attacken signifikant reduzieren kann. Für andere Kopfschmerzformen bietet sie eine sinnvolle Ergänzung zur medikamentösen Therapie. Medical treatment for certain chronic headache syndromes such as hemicrania continua (HC), chronic migraine (CM) or chronic cluster headache (CCH) is challenging and in many cases does not lead to sufficient pain relief or is limited by severe side effects. In the last few years neuromodulatory treatments such as subcutaneous stimulation of the greater occipital nerve or deep brain stimulation (DBS) in the hypothalamus have evolved. This report focuses on current knowledge and the results of peripheral subcutaneous nerve stimulation (SPNS) in the literature of the described headache syndromes and presents our own long-term results in ten patients. Technical details of implantation and possible complications are reported. The results between the two different stimulation types are compared. In summary, peripheral nerve stimulation of the greater occipital nerve is less invasive but also less effective in comparison to hypothalamic stimulation. However, the severity and frequency of pain attacks is significantly reduced. For other intractable headache syndromes SPNS of the greater occipital nerve offers a reasonable addition to medical treatment.
- 26 September 2010
- Published by Springer Nature in Der Schmerz
- Vol. 24 (5) , 441-448
Subkutane periphere Stimulation des N. occipitalis major zur Behandlung chronischer Kopfschmerzsyndrome
Die medikamentöse Therapie bestimmter Kopfschmerzsyndrome wie der chronischen Hemikranie (HC), chronischen Migräne (CM) oder dem chronischen Cluster-Kopfschmerz (CCH) führt in vielen Fällen nicht zu befriedigenden Ergebnissen oder ist durch intolerable Nebenwirkungen erschwert. In den letzten Jahren haben sich auch für diese Schmerzerkrankungen neuromodulative Therapien wie die subkutane Stimulation des N. occipitalis major oder die tiefe Hirnstimulation (DBS) im Hypothalamus entwickelt. Diese Arbeit soll eine Übersicht über den derzeitigen Wissensstand und die Resultate der subkutanen peripheren Nervenstimulation (SPNS) in der Literatur bei den beschriebenen Kopfschmerzformen geben und eigene Ergebnisse bei insgesamt 10 Patienten vorstellen. Hierbei wird auf technische Details bei der Implantation und mögliche Komplikationen eingegangen. Die Ergebnisse bei Cluster-Kopfschmerz werden mit denen der tiefen Hirnstimulation verglichen. Zusammenfassend lässt sich sagen, dass die SPNS beim Cluster-Kopfschmerz als weniger invasives Verfahren zwar nicht so erfolgreich ist wie die tiefe Hirnstimulation, aber dennoch die Häufigkeit und Schwere der Attacken signifikant reduzieren kann. Für andere Kopfschmerzformen bietet sie eine sinnvolle Ergänzung zur medikamentösen Therapie. Medical treatment for certain chronic headache syndromes such as hemicrania continua (HC), chronic migraine (CM) or chronic cluster headache (CCH) is challenging and in many cases does not lead to sufficient pain relief or is limited by severe side effects. In the last few years neuromodulatory treatments such as subcutaneous stimulation of the greater occipital nerve or deep brain stimulation (DBS) in the hypothalamus have evolved. This report focuses on current knowledge and the results of peripheral subcutaneous nerve stimulation (SPNS) in the literature of the described headache syndromes and presents our own long-term results in ten patients. Technical details of implantation and possible complications are reported. The results between the two different stimulation types are compared. In summary, peripheral nerve stimulation of the greater occipital nerve is less invasive but also less effective in comparison to hypothalamic stimulation. However, the severity and frequency of pain attacks is significantly reduced. For other intractable headache syndromes SPNS of the greater occipital nerve offers a reasonable addition to medical treatment.